J. Goldman & CO LP Insmed Inc Put Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$22.0 - $69.71 $297,000 - $941,084
13,500 New
13,500 $904,000
Q4 2019

Feb 14, 2020
SELL
$16.12 - $24.98 $483,600 - $749,400
-30,000 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$15.49 - $25.78 $1.55 Million - $2.58 Million
-100,000 Reduced 76.92%
30,000 $529,000
Q4 2018

Feb 14, 2019
BUY
$11.6 - $18.7 $1.51 Million - $2.43 Million
130,000 New
130,000 $1.71 Million

Others Institutions Holding INSM

# of Institutions
465
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email